MX2017001880A - Nutraceutical formulation made of pilocarpus microphyllus, lactoferrin and fish oil for oral administration in human beings. - Google Patents

Nutraceutical formulation made of pilocarpus microphyllus, lactoferrin and fish oil for oral administration in human beings.

Info

Publication number
MX2017001880A
MX2017001880A MX2017001880A MX2017001880A MX2017001880A MX 2017001880 A MX2017001880 A MX 2017001880A MX 2017001880 A MX2017001880 A MX 2017001880A MX 2017001880 A MX2017001880 A MX 2017001880A MX 2017001880 A MX2017001880 A MX 2017001880A
Authority
MX
Mexico
Prior art keywords
omega
vitamin
fish oil
lactoferrin
formulation
Prior art date
Application number
MX2017001880A
Other languages
Spanish (es)
Inventor
Carlos Altamirano Vallejo Juan
Santos Garcia Arturo
GONZÁLEZ SOTO Roberto
Original Assignee
Centro De Retina Medica Y Quirurgica Sc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Retina Medica Y Quirurgica Sc filed Critical Centro De Retina Medica Y Quirurgica Sc
Priority to MX2017001880A priority Critical patent/MX2017001880A/en
Publication of MX2017001880A publication Critical patent/MX2017001880A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present disclosure is related to a nutraceutical formulation for the oral consumption, made of jaborandi extract, fish oil (Omega-3 and Omega-6), recombinant human lactoferrin, Vitamin A and Vitamin E. The present invention is found within the field of ophthalmology and has been developed as an adjuvant to improve the signs of the ocular surface and the symptoms associated with the dry eye syndrome. This semi-liquid formulation, which is contained in soft gelatin capsules to facilitate its consumption and improve the absorption and bioavailability of its active compounds, contains a natural origin extract (pilocarpus microphyllus) which stimulates the aqueous secretion of the tear film, also using the eicosapentaenoic acid (EPA) omega 6 and docosahexaenoic acid (DHA) omega 3 which is obtained from fish oil, and that in conjunction with lactoferrin, vitamin A and vitamin E, an improvement in the quality of the tear is achieved by comprising antimicrobial and anti-inflammatory effects. This formulation has been designed to help in the therapy of those subjects with symptoms associated with dry eye syndrome.
MX2017001880A 2017-02-10 2017-02-10 Nutraceutical formulation made of pilocarpus microphyllus, lactoferrin and fish oil for oral administration in human beings. MX2017001880A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2017001880A MX2017001880A (en) 2017-02-10 2017-02-10 Nutraceutical formulation made of pilocarpus microphyllus, lactoferrin and fish oil for oral administration in human beings.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017001880A MX2017001880A (en) 2017-02-10 2017-02-10 Nutraceutical formulation made of pilocarpus microphyllus, lactoferrin and fish oil for oral administration in human beings.

Publications (1)

Publication Number Publication Date
MX2017001880A true MX2017001880A (en) 2018-08-09

Family

ID=64100039

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017001880A MX2017001880A (en) 2017-02-10 2017-02-10 Nutraceutical formulation made of pilocarpus microphyllus, lactoferrin and fish oil for oral administration in human beings.

Country Status (1)

Country Link
MX (1) MX2017001880A (en)

Similar Documents

Publication Publication Date Title
CL2017002939A1 (en) Topical pharmaceutical compositions
KR102665229B1 (en) Composition for treatment of dry eye disease and meibomianitis
RU2017125922A (en) COMPLEX ETHERS FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISEASES
HRP20151039T1 (en) Use of omega fatty acids for treating disease
AR105237A1 (en) METHOD AND NUTRITIONAL COMPOSITIONS CONTAINING PHOSFATIDYLETHANOLAMINE, SPPHINGOMYELINE AND DOCOSAHEXAENOIC ACID
HRP20201221T1 (en) Compositions of omega 3 fatty acids to treat diseases which involve damage to the nervous system
Cicero et al. Krill oil: evidence of a new source of polyunsaturated fatty acids with high bioavailability
EA201791885A1 (en) MIXTURE OF FATTY ACIDS AND ITS APPLICATION FOR THE TREATMENT OF INFLAMMATORY PATHOLOGIES
GEP20237543B (en) Pharmaceutical composition comprising omega fatty acids, and infusion preparation comprising the same
TR201903470T4 (en) Formulation for personal hygiene.
MX2017001880A (en) Nutraceutical formulation made of pilocarpus microphyllus, lactoferrin and fish oil for oral administration in human beings.
WO2012075093A3 (en) Topical formulations for administration of omega-3 fatty acids
PE20211003A1 (en) DHA ENRICHED POLYINSATURATED FATTY ACID COMPOSITIONS
RU2009145010A (en) COMPOSITION OMEGA-3 AND OMEGA-6 POLYUNSATURATED FATTY ACIDS
MX2017016991A (en) Oral administration formulation of blueberry extract as a coadjuvant for preserving the health of human precorneal film.
ES2666836T3 (en) Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration
ES2839877T3 (en) Combination of a retinoid and a diol and polyunsaturated fatty acid ester
MX2016010439A (en) Formulation for the oral administration of quercetin in human beings.
CL2022000255A1 (en) Lipid composition comprising antioxidants and natural polyphenols as a non-pharmacological alternative for the treatment and prevention of nafld.
EP3380092A1 (en) Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
WO2019004969A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an assistive agent in reduction of blood lipids known as triglyceride
ZA202104321B (en) Aqueous paediatric retinol formulations
RU2011143879A (en) PHARMACEUTICAL COMPOSITION BASED ON VEGETABLE DHA FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
NZ761512B2 (en) Prevention and/or treatment of neurodegenerative disease
TW201914585A (en) Composition for improving vision and intelligence and application thereof wherein the composition include DHA, algae oil, phospholipidylserine composition, mulberry extract and calendula extract